CD40 mediates retinal inflammation and neurovascular degeneration

Journal of Immunology

Volumn 181, Issue 12, 2008, Pages 8719-8726

  Portillo, Jose Andres C ^a   Van Grol, Jennifer ^a   Zheng, Ling ^a   Okenka, Genevieve ^a   Gentil, Katrin ^a   Garland, Alejandra ^a   Carlson, Eric C ^a   Kern, Timothy S ^a,b   Subauste, Carlos S ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CXCL1 CHEMOKINE; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; AUTACOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ANALYSIS; MALE; MOUSE; NERVE CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RETINA ISCHEMIA; RETINITIS; UPREGULATION; VASCULAR DISEASE; ANIMAL; C57BL MOUSE; CELL LINE; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; NERVE DEGENERATION; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY; REPERFUSION INJURY; RETINA BLOOD VESSEL; RETINA GANGLION CELL; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD40; CELL LINE; CHEMOTAXIS, LEUKOCYTE; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NERVE DEGENERATION; REPERFUSION INJURY; RETINAL GANGLION CELLS; RETINAL VESSELS; UP-REGULATION;

EID: 58849146197     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.12.8719     Document Type: Article

References (72)

1. Zheng, L., B. Gong, D. A. Hatala, and T. S. Kern. 2007. Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Invest. Ophthalmol. Visual Sci. 48: 361-367. (Pubitemid 47251425)
2. Joussen, A. M., V. Poulaki, M. L. Le, K. Koizumi, C. Esser, H. Janicki, U. Schraermeyer, N. Kociok, S. Fauser, B. Kirchlof, et al. 2004. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 18: 1450-1452.
3. Hangai, M., N. Yoshimura, K. Hiroi, M. Mandai, and Y. Honda. 1996. Inducible nitric oxide synthase in retinal ischemia-reperfusion injury. Exp. Eye Res. 63: 501-509. (Pubitemid 26420791)
4. Kern, T. S., and R. L. Engerman. 2001. Pharmacologic inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes 50: 1636-1642.
5. Zheng, L., Y. Du, C. Miller, R. A. Gubitosi-Klug, T. S. Kern, S. Ball, and B. A. Berkowitz. 2007. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 50: 1987-1996.
6. Sennlaub, F., F. Valamanesh, A. Vazquez-Tello, A. M. El-Asrar, D. Checchin, S. Brault, F. Gobeil, M. H. Beauchamp, B. Mwaikambo, Y. Courtois, et al. 2003. Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy. Circulation 108: 198-204. (Pubitemid 36871303)
7. Joussen, A. M., V. Poulaki, N. Mitsiades, B. Kirchhoff, K. Koizumi, S. Dohmen, and A. P. Adamis. 2002. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-α suppression. FASEB J. 16: 438-440.
8. Tsujikawa, A., Y. Ogura, N. Hiroshiba, K. Miyamoto, J. Kiryu, S. J. Tojo, M. Miyasaka, and Y. Honda. 1999. Retinal ischemia-reperfusion injury attenuated by blocking of adhesion molecules of vascular endothelium. Invest. Ophthalmol. Visual Sci. 40: 1183-1190. (Pubitemid 29211456)
9. Miyamoto, K., S. Khorsrof, S. E. Bursell, R. Rohan, T. Murata, A. C. Clermont, L. P. Aiello, Y. Ogura, and A. P. Adamis. 1999. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc. Natl. Acad. Sci. USA 96: 10836-10841.
10. Abu El-Asrar, A. M., S. Struyf, D. Kangave, K. Geboes, and J. van Damme. 2006. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Eur. Cytokine Network 17: 155-165.
11. Subauste, C. S. 2002. CD154 and type-1 cytokine response: from hyper IgM syndrome to human immunodeficiency virus infection. J. Infect. Dis. 185:S83-S89.
12. Andrade, R. M., M. Wessendarp, M. J. Gubbels, B. Striepen, and C. S. Subauste. 2006. CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes. J. Clin. Invest. 116: 2366-2377.
13. Subauste, C. S., and M. Wessendarp. 2006. CD40 restrains the in vivo growth of Toxoplasma gondii independently of γ interferon. Infect. Immun. 74: 1573-1579.
14. Thienel, U., J. Loike, and M. J. Yellin. 1999. CD154 (CD40L) induces human endothelial cell chemokine production and migration of leukocyte subsets. Cell Immunol. 198: 87-95. (Pubitemid 30086124)
15. Melter, M., M. E. J. Reinders, M. Sho, S. Pal, C. Geehan, M. D. Denton, D. Mukhopadhyay, and D. M. Briscoe. 2000. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 96: 3801-3808.
16. Jana, M., X. Liu, S. Koka, S. Ghosh, T. M. Petro, and K. Pahan. 2001. Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells. J. Biol. Chem. 276: 44527-44533. (Pubitemid 37391227)
17. Hollenbaugh, D., N. Mischel-Petty, C. P. Edwards, J. C. Simon, R. W. Denfeld, P. A. Kiener, and A. Aruffo. 1995. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182: 33-40.
18. Omari, K. M., R. Chui, and K. Dorovini-Zis. 2004. Induction of b-chemokine secretion by human brain microvessel endothelial cells via CD40/CD40L interactions. J. Neuroimmunol. 146: 203-208. (Pubitemid 38032973)
19. Okuno, T., Y. Nakatsuji, A. Kumanogoh, K. Koguchi, M. Moriya, H. Fujimura, H. Kikutani, and S. Sakoda. 2004. Induction of cyclooxygenase-2 in reactive glial cells by the CD40 pathway: relevance to amyotrophic lateral sclerosis. J. Neurochem. 91: 404-412. (Pubitemid 39363439)
20. Bagentose, L. M., R. K. Agarwal, P. B. Silver, D. M. Harlan, S. C. Hoffmann, R. L. Kampen, C.-C. Can, and R. R. Caspi. 2005. Disruption of CD40/CD40-ligand interactions in a retinal autoimmunity model results in protection without tolerance. J. Immunol. 175: 124-130.
21. Namba, K., K. Ogasawara, N. Kitaichi, T. Morohashi, Y. Sasamoto, S. Kotake, H. Matsuda, K. Iwabuchi, C. Iwabuchi, S. Ohno, and K. Onoe. 2000. Amelioration of experimental autoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposome and anti-CD40 ligand monoclonal antibody. J. Immunol. 165: 2962-2969. (Pubitemid 30728143)
22. Mach, F., U. Schonbeck, G. K. Sukhova, E. Atkinson, and P. Libby. 1998. Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature 394: 200-203. (Pubitemid 28325976)
23. Lutgens, E., K. B. Cleutjens, S. Heeneman, V. E. Koteliansky, L. C. Burkly, and M. J. Daemen. 2000. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc. Natl. Acad. Sci. USA 97: 7464-7489.
24. Gerritse, K., J. D. Laman, R. J. Noelle, A. Aruffo, J. A. Ledbetter, W. J. Boersma, and E. Claassen. 1996. CD40-CD40 ligand interactions in experimental allergic encephalitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA 93: 2499-2504.
25. Okabe, M., M. Ikawa, K. Komitnami, T. Nakanishi, and Y. Nishimune. 1997. "Green mice" as a source of ubiquitous green cells. FEBS Lett. 407: 313-319. (Pubitemid 27199450)
26. van Parijs, L., Y. Refaeli, A. K. Abbas, and D. Baltimore. 1999. Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes. Immunity 11: 763-770.
27. Zheng, L., C. Szabo, and T. S. Kern. 2004. Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor κB. Diabetes 53: 2960-2967. (Pubitemid 39425922)
28. Kern, T. S., J. Tang, M. Mizutani, R. A. Kowluru, R. H. Nagaraj, G. Romeo, F. Podesta, and M. Lorenzi. 2000. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest. Ophthalmol. Visual Sci. 41: 3972-3978.
29. + T cells from HIV-1-infected patients. J. Immunol. 178: 1645-1653.
30. Park, E.-M., S. Cho, K. Frys, G. Racchumi, P. Zhou, J. Anrather, and C. Iadecola. 2004. Interaction between inducible nitric oxide synthase and polyADP-ribose polymerase in focal ischemic brain injury. Stroke 35: 2896-2901.
31. Wei, X., X. Zhang, M. J. Zuscik, M. H. Drissi, E. M. Schwarz, and R. J. O'Keefe. 2005. Fibroblasts express RANKL and support osteoclastogenesis in a COX-2-dependent manner after stimulation with titanium particles. J. Bone Min. Res. 20: 1136-1148. (Pubitemid 40863801)
32. Zhou, J. T., L. Pham, N. Zhang, S. He, M.-A. Gamulescu, C. Spee, J. Ryan, and D. R. Hinton. 2005. Neutrophils promote experimental choroidal neovascularization. Mol. Vision 11: 414-424.
33. Zaheer, A., S. K. Sahu, Y. Wu, A. Zaheer, J. Haas, K. Lee, and B. Yang. 2007. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis. Brain Res. 1144: 239-247. (Pubitemid 46440840)
34. Su, X., C. M. Sorenson, and N. Sheibani. 2003. Isolation and characterization of murine retinal endothelial cells. Mol. Vision. 9: 171-178. (Pubitemid 38097583)
35. Scheef, E., S. Wang, C. M. Sorenson, and N. Sheibani. 2005. Isolation and characterization of murine retinal astrocytes. Mol. Vision 11: 613-624. (Pubitemid 41410213)
36. Stone, G. W., S. Barzee, V. Snarsky, K. Kee, C. A. Spina, X.-F. Yu, and R. S. Kornbluth. 2006. Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines. J. Virol. 80: 1762-1772.
37. + T cells from HIV-infected individuals. J. Infect. Dis. 189: 61-70.
38. Sennlaub, F., Y. Courtois, and O. Goureau. 2002. Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy. J. Neurosci. 22: 3987-3993.
39. Neufeld, A. H., S. Kawai, S. Das, S. Vora, E. Gachie, J. R. Connor, and P. T. Manning. 2002. Loss of retinal ganglion cells following retinal ischemia: the role of inducible nitric oxide synthase. Exp. Eye Res. 75: 521-528.
40. Iadecola, C., K. Niwa, S. Nogawa, X. Zhao, M. Nagayama, E. Araki, S. Morham, and E. Ross. 2001. Reduced susceptibility to ischemic brain injury and N-methyl- D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl. Acad. Sci. USA 98: 1294-1299. (Pubitemid 32121226)
41. Ju, W.-K., and A. H. Neufeld. 2002. Cellular localization of cyclooxygenase-1 and cyclooxygenase-2 in the normal mouse, rat, and human retina. J. Compar. Neurol. 452: 392-399.
42. Armstrong, D. A., J. A. Major, A. Chudyk, and T. A. Hamilton. 2004. Neutrophil chemoattractant genes KC and MIP-2 are expressed in different cell populations at sites of surgical injury. J. Leukocyte Biol. 75: 641-648.
43. Tout, S., T. Chan-Ling, H. Hollander, and J. Stone. 1993. The role of Muller cells in the formation of the blood-retinal barrier. Neuroscience 55: 291-301.
44. Yoneda, S., H. Tanihara, N. Kido, Y. Honda, W. Goto, H. Hara, and N. Miyawaki. 2001. Interleukin-1β mediates ischemic injury in the rat retina. Exp. Eye Res. 73: 661-667.
45. Strieter, R. M., S. L. Kunkel, H. J. Showell, D. G. Remick, S. H. Phan, P. A. Ward, and R. M. Marks. 1989. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1β. Science 243: 1467-1469.
46. Choi, J. S., D. Kim, Y. M. Hong, S. Mizuno, and C. K. Joo. 2006. Inhibition of nNOS and COX-2 expression by lutein in acute retinal ischemia. Nutrition 22: 668-671.
47. Vinores, S. A., W. H. Xiao, S. J., and P. A. Campochiaro. 2007. TNF-α is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGFinduced leakage. J. Neuroimmunol. 182: 73-79.
48. Yngen, M., C.-G. Ostenson, H. M. Hu, N. Li, P. Hjemdahl, and N. H. Wallen. 2004. Enhanced P-selectin expression and increased soluble CD40 ligand in patients with type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation. Diabetologia 47: 537-540. (Pubitemid 38491251)
49. Cipollone, F., F. Chiarelli, G. Davi, C. Ferri, G. Desideri, M. Fazia, A. Iezzi, F. Santilli, B. Pini, C. Cuccurullo, et al. 2005. Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control. Diabetologia 48: 1216-1224.
50. Newman, E., and A. Reichenbach. 1996. The Muller cell: a functional element of the retina. Trends Neurosci. 19: 307-312. (Pubitemid 26349058)
51. Gerbardinger, C., M. Biarnes Costa, M. C. Coulombe, I. Toth, T. Hoehn, and P. Grosu. 2005. Expression of acute-phase response proteins in retinal Muller cells in diabetes. Invest. Ophthalmol. Visual Sci. 46: 349-357.
52. Powers, M. R., M. H. Davies, and J. P. Eubanks. 2005. Increased expression of chemokine KC, an interleukin-8 homologue, in a model of oxygen-induced retinopathy. Curr. Eye Res. 30: 299-307.
53. Joussen, A. M., T. Murata, A. Tsujikawa, B. Kirchhof, S. E. Bursell, and A. P. Adamis. 2001. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am. J. Pathol. 158: 147-152.
54. Hu, L., V. M. Dixit, V. de Mello-Coelho, and D. D. Taub. 2004. Age-associated alterations in CXCL1 chemokine expression by murine B cells. BMC Immunol. 5: 1-14.
55. Miura, M., X. Fu, Q.-W. Zhang, D. G. Remick, and R. L. Fairchild. 2001. Neutralization of Groα and macrophage inflammatory protein-2 attenuates renal ischemia/ reperfusion injury. Am. J. Pathol. 159: 2137-2145.
56. Huo, Y., C. Weber, S. B. Forlow, M. Sperandio, J. Thatte, M. Mack, S. Jung, D. R. Littman, and K. Ley. 2001. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J. Clin. Invest. 108: 1307-1314. (Pubitemid 33107758)
57. Jo, N., G.-S. Wu, and N. A. Rao. 2003. Upregulation of chemokine expression in the retinal vasculature in ischemia-reperfusion injury. Invest. Ophthalmol. Visual Sci. 44: 4054-4060. (Pubitemid 37047982)
58. Mizushima, H., C. J. I. Zhou, K. Dohi, R. Horai, M. Asano, Y. Iwakura, T. Hirabayashi, S. Arata, S. Nakajo, A. Takaki, H. Ohtaki, and S. Shioda. 2002. Reduced postischemic apoptosis in the hippocampus of mice deficient in interleukin- 1. J. Comp. Neurol. 448: 203-216. (Pubitemid 34538768)
59. van Kooten, C., X. van der Linde, A. M. Woltman, L. A. van Es, and M. R. Daha. 1999. Synergistic effect of interleukin-1 and CD40L on the activation of human renal tubular epithelial cells. Kidney Int. 56: 41-51.
60. Patrick, A. L., J. Rullo, S. Beaudin, P. Liaw, and A. E. Fox-Robichaud. 2007. Hepatic leukocyte recruitment in response to time-limited expression of TNF-α and IL-1β. Am. J. Physiol. 293:G663-G672. (Pubitemid 47605935)
61. Walford, G. A., R. L. Moussignac, A. W. Scribner, J. Loscalzo, and J. A. Leopold. 2004. Hypoxia potentiates nitric oxide-mediated apoptosis in endothelial cells via peroxynitrite-induced activation of mitochondria-dependent and -independent pathways. J. Biol. Chem. 279: 4425-4432.
62. Zheng, L., S. J. Howell, D. A. Hatala, K. Huang, and T. S. Kern. 2007. Salicylatebased anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes 56: 337-345. (Pubitemid 46263071)
63. Kawano, T., J. Anrather, P. Zhou, L. Park, G. Wang, K. A. Frys, A. Kunz, S. Cho, M. Orio, and C. Iadecola. 2006. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat. Med. 12: 225-229. (Pubitemid 43214750)
64. Du, Y., V. P. Sarthy, and T. S. Kern. 2004. Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. Am. J. Physiol. 287: R735-R741. (Pubitemid 39280457)
65. Kern, T. S., C. M. Miller, Y. Du, L. Zheng, S. Mohr, S. L. Ball, M. Kim, J. A. Jamison, and D. P. Bingaman. 2007. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Diabetes 56: 373-379.
66. Abu El-Asrar, A. M., S. Desmet, A. Meersschaert, L. Dralands, L. Missotten, and K. Geboes. 2001. Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am. J. Ophthalmol. 132: 551-556. (Pubitemid 32904579)
67. Kobayashi, M., T. Kuroiwa, R. Shimokawa, R. Okeda, and T. Tokoro. 2000. Nitric oxide synthase expression in ischemic rat retinas. Jpn. J. Ophthalmol. 44: 235-244. (Pubitemid 30417512)
68. Ishikawa, M., T. Vowinkel, K. Y. Stokes, T. V. Arumugam, G. Yilmaz, A. Nanda, and D. N. Granger. 2005. CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion. Circulation 111: 1690-1696. (Pubitemid 40525171)
69. Moore, T. M., W. B. Shirah, P. L. Khimenko, P. Paisley, R. N. Lausch, and A. E. Taylor. 2002. Involvement of CD40-CD40L signaling in postischemic lung injury. Am. J. Physiol. 283: L1255-L1262.
70. Shen, X.-D., B. Ke, Y. Zhai, F. Amersi, F. Gao, D. M. Anselmo, R. W. Busuttil, and J. W. Kuplec-Weglinski. 2002. CD154-CD40 T-cell costimulation pathway is required in the mechanism of hepatic ischemia/reperfusion in jury, and its blockade facilitates and depends on heme oxygenase-1 mediated cytoprotection. Exp. Transpl. 74: 315-319.
71. Kawai, T., D. Andrews, R. B. Colvin, D. H. Sachs, and B. Cosimi. 2000. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat. Med. 6: 114. (Pubitemid 30082329)
72. Boumpas, D. T., R. Furie, S. Manzi, G. G. Ilei, D. J. Wallace, J. E. Balow, and A. Vaishnaw. 2003. A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis. Arthritis Rheum. 48: 719-727.